Prognostic value of cyp2b6 gene polymorphism in patients with acute myeloid leukemia prognostic value of cyp2b6 gene polymorphism in patients with acute myeloid leukemia

HIGHLIGHTS

• who: CYP et al. from the Before starting the data collection, an informed written consent was obtained from each patientThe study included , newly diagnosed AML patients that were presented to the Adult Oncology Department, National Cancer Institute (NCI), Cairo University, between January , and January, . Clinical, morphological, cytochemical, and flow cytometric analyses were done for proper diagnosis. The patients were composed of , (61.7%) males and , (39.02%) females. The CYP , frequency demonstrated a remission status, which was detected after the first cycle, at , days, in relation to patient outcome. With respect to all patient privacy, patients were . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.